Pathology and CT Microdosimetry of Eye90 Treated Hepatocellular Carcinoma

Clinical Trial Details

This research study is being conducted to better understand how the Eye90 radiation treatment affects liver tumors.

After a patient undergoes transplant surgery, the removed liver tissue will be examined using detailed imaging and microscope techniques to study how well the treatment worked and how the radiation particles were distributed in the tumor.

No additional tests, procedures, or visits are required for participation in this study.

Key Eligibility: 
  1. Open to adults (18 years or older) with liver cancer (hepatocellular carcinoma).
  2. Participants must have previously received Eye90 radioembolization treatment and be scheduled for liver transplant surgery.
  3. Participants must be able to provide informed consent.
  4. Individuals are not eligible if they are not undergoing transplant surgery or did not receive Eye90 treatment.

Detailed eligibility will be reviewed when contacting the study team.

Study contact by location

Upper East Side - Manhattan

Contact(s)

Adam Talenfeld, MD
adt9010@med.cornell.edu

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:

2603030049

Status

Open to Enrollment

Age Group

Adult

Sponsor